This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...

GlaxoSmithKline (GSK) is to collaborate with the Francis Crick Institute, a new powerhouse of academic- and charity-funded biomedical research based in London. The new partnership is expected to ...

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for ...

As 2024 draws to a close, we explore five stocks to buy for a new year that promises opportunity alongside uncertainty ...

Shares in French media giant Canal+ fell by 16pc in early trading on Monday, dampening optimism around London’s biggest ...

The UK S&P Global consumer sentiment index fell to 46.6 in December from 46.9 in November. The spending sentiment index contracted to 39.7 from 40.4. Perhaps more positively, the labour market ...

Teva Pharmaceutical Industries Ltd. ADR 26.47% $18.82B ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Bloomberg editor John Micklethwait has called paywalls “the safest way to guarantee journalistic jobs” in a speech about ...

Canal+ has suffered a disappointing debut on the London Stock Exchange with the French film production firm's shares ...